ALMS
ALMS
NASDAQ · Pharmaceuticals

Alumis Inc

$7.90
+0.13 (+1.67%)
Day Range $7.56 — $7.92
52W Range $3.76 — $31.35

Performance

1D
1W
1M
3M
6M
1Y +90.36%
YTD -11.78%
Open$7.82
Previous Close$7.77
Day High$7.92
Day Low$7.56
52W High$31.35
52W Low$3.76
Volume
Avg Volume4.35M
Market Cap1.04B
P/E Ratio
EPS$-3.81
SectorPharmaceuticals

Technical Indicators

Full analysis →
SMA 50 $19.51 Below
SMA 200 $8.26 Below
RSI (14) 60.5 Neutral
Trend Golden Cross Bullish

Analyst Ratings

Strong Buy
16 analysts
14 Buy 2 Hold 0 Sell
Price Target +210.3% upside
Current
$7.90
Target
$24.51
$15.34 $24.51 avg $36.47

Key Financials

FY 2026 FY 2025 FY 2024
Revenue 37.75M 878.33M 917.39M
Net Income -382,009,715 120.27M 166.79M
Profit Margin -1,011.8% 13.7% 18.2%
EBITDA -411,966,026 272.46M 241.94M
Free Cash Flow 126.96M 147.40M
Rev Growth +6.0% +16.1%
Debt/Equity 0.25 0.30

Pharmaceuticals Peers

Symbol Name Price Change P/E Mkt Cap
LLY Eli Lilly and Co. $1,164.89 +1.04% 40.7 1.09T
JNJ Johnson & Johnson $269.47 -0.19% 30.6 644.12B
MRK Merck & Co. Inc. $149.50 +1.79% 114.0 361.66B
PFE Pfizer Inc. $27.74 +0.29% 36.4 157.54B
BMY Bristol-Myers Squibb Co $62.62 -0.70% 13.9 128.81B
ZTS Zoetis Inc $71.33 -0.10% 11.5 30.15B